Dr. Matt Chalmers - Ozampic

THE CASE FOR OZEMPIC AS A ADDICTION TREATMENT KEEPS GETTING BETTER

Research is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's addiction to both opioids and alcohol.  The sky continues to be the limit for semaglutide, the active ingredient in popular drugs Ozempic and Wegovy. Newly published research is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people’s addiction to both opioids and alcohol.  GLP-1 drugs have been a valuable treatment for type 2 diabetes for nearly twenty years. More recently, they’ve substantially changed the landscape of obesity treatment, with clinical trials showing that the newest medications like semaglutide are far more effective at helping people lose weight than diet and exercise alone. Researchers have also now started to study whether GLP-1s can reduce people’s cravings for potentially harmful substances like opioids or alcohol. So far, the evidence for this effect has largely come from animal studies, people’s personal anecdotes, and small studies of GLP-1 users. This new research, published Wednesday in the journal Addiction, takes a more expansive look at the possible benefits of GLP-1s for substance use disorders. Dr. Chalmers is A healthy living expert who takes a holistic approach to healing by looking at the mind, body and spirit of his patients